7H-Pyrrolo[2,3-d]pyrimidine-6-carboxylic acid, 95.0%, 100mg

Trimethylsulfoxonium Chloride>98.0%(T)5g

Tert-butyl 4-(4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine-1-carboxylate, 95%, 5g

H-Arg-OH, 98%, 100g

4-Methyl-2-[1-(tert-butoxycarbonyl)piperid-4-yl]1,3-thiazole-5-carboxylic acid, 1g

N-Methoxy-4-nitrobenzenesulfonamide, 98%, 1g

E-Plan phase EPLPHi S40x/0.65 infinity corrected IOS lens. Working distance 0.78 mm

5-chloro-1-phenyl-3-propyl-1H-pyrazole-4-carbaldehyde, 95.0%, 10g

2-(Tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole, 97%, 5g

DL-2-(4-Chlorophenyl)glycine>98.0%(T)25g

2-(2-aminoethyl)-4-methyl-1,3-thiazole-5-carboxylic acid, 95.0%, 1g

5-Benzylimidazolidine-2,4-dione, 97%, 100mg

3-BROMO-2-(TRIFLUOROMETHYL)ANILINE, 95.0%, 1g